We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+21.79%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$1.16B
AUM Growth
+$372M
Cap. Flow
+$132M
Cap. Flow %
11.39%
Top 10 Hldgs %
68.38%
Holding
232
New
129
Increased
24
Reduced
12
Closed
56

Top Buys

Rank Stock Value
1
SANA icon
Sana Biotechnology
SANA
+$72.8M
2
PBR.A icon
Petrobras Class A
PBR.A
+$20.9M
3
AMP icon
Ameriprise Financial
AMP
+$11.4M
4
MET icon
MetLife
MET
+$10.1M
5
WFC icon
Wells Fargo
WFC
+$7.59M

Top Sells

Rank Stock Value
1
DNLI icon
Denali Therapeutics
DNLI
+$114M
2
MU icon
Micron Technology
MU
+$7.77M
3
UDR icon
UDR
UDR
+$5.92M
4
EQH icon
Equitable Holdings
EQH
+$4.95M
5
LRCX icon
Lam Research
LRCX
+$4.46M

Sector Composition

Rank Sector Weight
1 Healthcare 61.94%
2 Financials 15.05%
3 Materials 5.33%
4 Technology 3.84%
5 Energy 2.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIDI
101
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$711K 0.06%
+50,285
New +$711K
GRNA
102
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$507K 0.04%
51,684
+40,000
+342% +$390K
TMTS
103
DELISTED
Spartacus Acquisition Corporation Class A Common Stock
TMTS
$507K 0.04%
+50,400
New +$502K
SABS icon
104
SAB Biotherapeutics
SABS
$273M
$505K 0.04%
+5,061
New +$502K
OCAX
105
DELISTED
OCA Acquisition Corp. Class A Common Stock
OCAX
$505K 0.04%
+51,002
New +$504K
ICU icon
106
SeaStar Medical
ICU
$12.5M
$504K 0.04%
+204
New +$505K
QFTA
107
DELISTED
Quantum FinTech Acquisition Corporation
QFTA
$504K 0.04%
+51,700
New +$504K
SYNH
108
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$504K 0.04%
+5,627
New +$475K
OSTR
109
DELISTED
Oyster Enterprises Acquisition Corp. Class A Common Stock
OSTR
$504K 0.04%
+52,100
New +$505K
FOXO
110
DELISTED
FOXO TECHNOLOGIES INC A
FOXO
$503K 0.04%
+258
New +$503K
EDTX
111
DELISTED
EdtechX Holdings Acquisition Corp. II Class A common stock
EDTX
$503K 0.04%
+50,700
New +$503K
AENT icon
112
Alliance Entertainment
AENT
$276M
$502K 0.04%
+51,650
New +$503K
EPWR
113
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
$502K 0.04%
51,374
+25,474
+98% +$248K
ISLE
114
DELISTED
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
$502K 0.04%
+51,215
New +$500K
HGAS
115
DELISTED
Global Gas Corporation Class A Common Stock
HGAS
$501K 0.04%
+51,233
New +$501K
PMGM
116
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$501K 0.04%
+51,350
New +$501K
LJAQ
117
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
$499K 0.04%
51,100
+25,500
+100% +$250K
SHAC
118
DELISTED
SCP & CO Healthcare Acquisition Company Class A Common Stock
SHAC
$499K 0.04%
+51,500
New +$501K
CXAI icon
119
CXApp
CXAI
$13.4M
$498K 0.04%
+50,522
New +$499K
GRDI
120
DELISTED
GRIID Infrastructure Inc. Common Stock
GRDI
$498K 0.04%
+51,400
New +$499K
PUCK
121
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$497K 0.04%
+51,550
New +$499K
ELIQ
122
DELISTED
Electriq Power Holdings, Inc.
ELIQ
$497K 0.04%
+51,400
New +$500K
ASAX
123
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
$497K 0.04%
+51,400
New +$499K
ALTU
124
CALL
DELISTED
Altitude Acquisition Corp
ALTU
$490K 0.04%
+50,000
New +$493K
ALTU
125
DELISTED
Altitude Acquisition Corp
ALTU
$490K 0.04%
+50,000
New +$493K

Similar funds

Crestline Management's Q2 2021 Portfolio in Review

As of Q2 2021, Crestline Management held 232 positions worth $1.16B, up 47% from $788M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Crestline Management deployed $132M of net new capital in Q2 2021, opening 129 new positions and adding to 24 existing holdings. Its largest new stake was Sana Biotechnology: 3,210,937 shares worth $63.1M.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 72% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Denali Therapeutics, an estimated $114M trimmed.

  • Crestline Management's largest Q2 2021 buy was Sana Biotechnology: 3,210,937 shares worth $63.1M.
  • Crestline Management added most to Travelers Companies in Q2 2021, an estimated $6.82M increase.
  • Crestline Management's biggest Q2 2021 reduction was Denali Therapeutics, cutting an estimated $114M.
  • Crestline Management fully exited Micron Technology in Q2 2021, selling an estimated $7.77M.
  • Crestline Management's ten largest holdings make up 68% of its $1.16B portfolio in Q2 2021.
  • Crestline Management opened 129 new positions and closed 56 in Q2 2021.
  • Crestline Management's portfolio value rose 47% quarter-over-quarter to $1.16B.

Based on Crestline Management's 13F filing for Q2 2021, filed 13 Aug 2021.